Cancer Therapy Market, By Treatment Type (Chemotherapy, Target Therapy, Immunotherapy Therapy, Hormone Therapy, and Others), By Cancer Type (Blood Cancer, Breast Cancer, Prostate cancer, Skin Cancer, Lung Cancer, and Others), and By End User (Hospital, Sp

Cancer Therapy Market, By Treatment Type (Chemotherapy, Target Therapy, Immunotherapy Therapy, Hormone Therapy, and Others), By Cancer Type (Blood Cancer, Breast Cancer, Prostate cancer, Skin Cancer, Lung Cancer, and Others), and By End User (Hospital, Specialty Clinic, and Radiation Center), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cancer therapies, such as chemotherapy, radiation therapy, immunotherapy, and targeted therapy, help cure a cancer, shrink a cancer, or stop the progression of a cancer. Chemotherapy uses drugs to kill cancer cells. It is a drug treatment that uses powerful chemicals to kill fast-growing cells in the body. Radiation therapy is the use of high-energy radiation to treat cancer. An immunotherapy is a type of cancer treatment that helps the immune system fight cancer. Targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread.

Market Dynamics:

Rising prevalence of cancer worldwide, increase in demand for safe and effective cancer therapy, government initiatives for cancer awareness, and increase in research and development initiatives by key players are major factors expected to drive growth of the global cancer therapy market.

For instance, according to the Indian Council for Medical Research (ICMR), the number of Indians suffering from cancer is expected to rise to 29.8 million in 2025 from 26.7 million in 2021. Thus, with the increase in prevalence of cancer, the demand for cancer therapy, diving the growth of the global cancer therapy market in the region.

Moreover, in March 2022, the U.S. Food and Drug Administration (FDA) approved a new therapy that zeros in on cancer cells to destroy them. The treatment, 177Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface called PSMA (prostate-specific membrane antigen). The technology delivers radiation that damages DNA and destroys the cancer cell.

Key features of the study:

• This report provides in-depth analysis of the global cancer therapy market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cancer therapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Pfizer Inc., Novartis AG, Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline PLC, Hoffmann-La Roche Ltd., Bayer AG, AstraZeneca, Amgen, and Bristol-Myers Squibb Company, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global cancer therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapy market.

• Global Cancer Therapy Market, By Treatment Type:
• Chemotherapy
• Target Therapy
• Immunotherapy Therapy
• Hormone Therapy
• Others
• Global Cancer Therapy Market, By Cancer Type:
• Blood Cancer
• Breast Cancer
• Prostate cancer
• Skin Cancer
• Lung Cancer
• Others
• Global Cancer Therapy Market, By End User:
• Hospital
• Specialty Clinic
• Radiation Center
• Global Cancer Therapy Market, By Geography:
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America
• Company Profiles:
• Pfizer Inc.
• Novartis AG
• Merck & Co. Inc.
• Johnson & Johnson
• GlaxoSmithKline PLC
• Hoffmann-La Roche Ltd.
• Bayer AG
• AstraZeneca
• Amgen
• Bristol-Myers Squibb Company